D-0
Title | Holixer - The New Age Adaptogen for Stress & Sleep Management |
---|---|
Date | 2024.08.27(10:20 - 10:50) | Hall A Seminar Room |
Organization | EverSpring |
Speaker | Akrati Singh, Senior Manager |
<Brief Introduction of Seminar>
Unlock the inner calm and restful nights with Holixer™!
This comprehensive approach will provide invaluable data on the specific mechanisms by which Holixer™ promotes a restorative sleep.
<Brief Introduction of Speaker>
Akrati Singh is a seasoned professional with 15 years of experience traversing the globe to source and develop innovative natural ingredients.
A blend of technical knowledge, global experience, and business!
F-6-3
Title | Implementation of the Nagoya Protocol(and ABS) and notification |
---|---|
Date | 2023.09.01 (13:40 - 15:30) |
Organization | Cosmax |
Speaker | Yong Seok Jwon, Legal Department Chief Legal Officer |
▷Speaker
Korea University Law School (Intellectual Property Law)
Cosmax Legal Department Chief Legal Officer(September 2016 ~ present)Samsung Electronics Semiconductor Lab/Legal Office (January 2001 ~ May 2008)
D-1-1
Title | The meaning of 'National Biotechnology and Biomanufacturing Initiative' and our response |
---|---|
Date | 2023.08.30 (10:30 - 11:10) |
Organization | Korea Pharmaceutical and Bio-Pharma Manufacturers Association |
Speaker | Chi-Min Kim, Policy Department, Researcher Team, Director |
▷Speaker
- (Present) KPBMA Researcher Team, Director/doctor of laws
- KRIBB Researcher
- U1 university Assistant Professor
• Policy and institutional research in the bio/pharmaceutical field
• MFDS, MOHW, MSIT Policy research and R&D project implementation
▷Lecture
1. Review of the international background regarding the Executive Order* signed by President Biden
* Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy
2. Main contens of the President's Executive Order and a new report*
* Bold Goals for U.S. Biotechnology and Biomanufacturing
3. The meaning of 'National Biotechnology and Biomanufacturing Initiative' in the biopharmaceutical industry and our response
D-1-2
Title | Highlights of the U.S. Executive Order and Our Assignment |
---|---|
Date | 2023.08.30 (11:10 - 11:40) |
Organization | Korea Research Institute of Bioscience and Biotechnology |
Speaker | Hyeon su KIM, Team Manager |
▷Speaker
I work at the National Biotechnology Policy Research Center at KIRBB.
I conduct bio policy research and provide support to government departments such as the Ministry of Science and ICT.
I specialise in bio-law and regulation.
▷Lecture
I'll be discussing the key follow-ups to the executive orders issued by the Biden administration in the US.
I will also discuss the issues that the executive order raises for us to think about together.
D-1-3
Title | Unlocking the Potential: Case Studies of Bio Supply Chain Utilization Plan |
---|---|
Date | 2023.08.30 (11:40 - 12:20) |
Organization | Korea-US Supply Chain Management Institute (KUSCMI) |
Speaker | Park Young Ho, Representative |
▷Speaker
ASC.PBC Affiliation
. professional specialist
. supply chain manager
-regulatory services divison
▷Lecture
-Driving Global Growth: A Strategy for Advancing Korea's Bioindustry
-Navigating the Path to Success: Expanding into the US FDA-Regulated Contract Manufacturing Market
D-3
Title | Elsevier’s Life Science Solutions for Pharmaceutical Research |
---|---|
Date | 2023.08.30 (12:20 - 12:50) |
Organization | Elsevier |
Speaker | Sejin Kim, Customer Consultant |
▷Speaker
Elsevier Life Science Team Customer Consultant
▷Lecture
Elsevier, a global leader in information and analytics tool, helps researchers and healthcare professionals to advance science and improve health outcomes to make breakthroughs and drive societal progress. We extract reliable data from scientific literature to support corporate R&D professionals, save time, make better decisions, ensure a thriving R&D pipeline, innovate, targeted drugs, increase research efficiency.
Our life science solutions for pharmaceutical customers include, Reaxys, Embase and Pharmapendium.
It combines trusted data and analytics to augment data-driven critical drug discovery and business challenges, including synthesis of new substances and efficiently monitoring post-market drug safety literature. In this webinar,
Customer Consultant Mr Sejin Kim will discuss:
• Introduce solutions that are available throughout the discovery and development lifecycle of medicines
• How to predict outcomes to make critical development and risk decisions
• How the semantic technology manages post-market surveillance effectively to maximize safety
D-4-1
Title | The potential of Gelucire® 44/14 as a solubilizer and its pharmaceutical applications in SEDDS(Self-emulsifying drug delivery system) formulation |
---|---|
Date | 2023.08.30 (13:00 - 14:10) |
Organization | College of Pharmacy, Chung-Ang University |
Speaker | Sangkil Lee, Professor |
▷Speaker
The speaker gained B.A (1997. 02), M.S (1999. 02), and Ph.D (2003. 02) from college of pharmacy, Chung-Ang University, republic of Korea and he joined in Daewoong Pharmaceutical company from 2003. 04 to 2007. 02.
He served as assistant professor at pharmaceutical
engineering/college of pharmacy, Inje University and professor of Keimyung
university from 2012. 03 to 2023. 02. From 2023. 02 to the present, he is
serving as full professor of college of pharmacy, Chung-Ang University. He has
been conducting research on the enhancement of solubility and absorption of
water insoluble drugs. Recently, he is conducting research on brain drug
delivery and oral delivery of biopharmaceuticals.
▷Lecture
In this seminar, the presenter will give recently updated informations on Gelucire® 44/14 and its latest research trends in pharmaceutical applications as well as strategies for use in SEDDS development
D-4-2
Title | 고형 SEDDS 제제의 난용성 약물에 대한 지질 부형제의 이점 |
---|---|
Date | 2023.08.30 (13:00 - 14:10) |
Organization | Gattefosse SAS |
Speaker | Philippe CAISSE, Scientific Director Pharmaceuticals |
▷Speaker
Philippe is a chemist and polymer scientist graduated from Teesside Polytechnic and Loughborough University.
He has joined Gattefossé
since 2020, as Scientific Director of the Pharma Group, leading the French
Technical Center of Excellence in Lyon, which provides technical support to
clients, formulation assessment and customized training.
His key expertise includes
lipid formulation design for poorly soluble and poorly permeable drugs, oral
bioavailability enhancement and sustained release dosage forms.
He also coordinates the
three other international Technical Centers of Excellence, as well as managing
academic research collaborations.
Philippe’s 30 years of
previous industrial experience cover the full spectrum of pharmaceutical drug
product development, from early-stage formulation to commercial scale up.
▷Lecture
o Benefits of lipid excipients for poorly soluble drugs in solid SEDDS formulations, by Philippe (25 min)
· Introduction
· Case study on Solid SMEDDS Gelucire® 48/16 to enhance bioavailability of atorvastatin (25 min)
D-6
Title | The Health Benefits and Application Advantages of FloraFocus® Probiotics from BioGrowing |
---|---|
Date | 2023.08.30 (14:20 - 14:50) |
Organization | BIOGRWOING CO., LTD |
Speaker | Dr. Haidi XU, Vice General Manager, Strategy & Innovation Center |
▷Speaker
Dr. Xu got her PhD degree in Food Science at Purdue University and MBA at INSEAD Business School. Her doctoral research focused on the relationship between fine structures of dietary fiber and gut health.
Has more than ten years of cross-functional work experience with international companies in intestinal health, weight and blood sugar management, immune health and healthy aging area.
Has accumulated solid scientific background and business development experience.
▷Lecture
The core health benefits of probiotics are supporting gut health and immune health, which are gradually recognized by mass consumers, especially after the pandemic period and education.
In addition, due to the diverse concepts of “Gut-X Axis”, probiotics are also considered and explored as alternative solutions to different systematic health issues.
FloraFocus probiotics from BioGrowing provide a series of strains or strain mixture with various scientifically proven health benefits.
The scientific evidences for different probiotic solution, including clinical and preclinical studies, will be shown and discussed.